<p>Frequency of detection of target mRNAs in benign prostate tissue from patients without PCa (CP-B samples) and with incidental PCa (CP-IPCa samples) and in histologically benign (RP-B samples) and cancerous (RP-PCa) tissue of patients with PCa.</p
<p>Detection was performed by RT-PCR <b>(A)</b>, or Western blot analyses <b>(B, C)</b>. Shown are r...
We characterized the expression and localization of pituitary adenylate cyclase-activating polypepti...
BACKGROUND:Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer ...
Objectives: Our aim was to verify whether the quantitative determination of PSA mRNA in circulating ...
Prostate-specific antigen (PSA) is important in tumour detection, monitoring disease progression and...
Objectives: The benefits of PSA (prostate specific antigen)-testing in prostate cancer remain contro...
Abstract Background Gene expression profiling has recently shown that the mRNA for CD24 is overexpre...
PCA3 is a prostate-specific non-coding RNA, with utility as urine based early detection biomarker. H...
lower ratio of free prostate-specific antigen (fPSA) to total PSA (tPSA) in serum than patients with...
Objectives. To ascertain when the serum determination of the free prostate-specific antigen (PSA)/to...
Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer (PCa). We r...
Objective: The objective of this study is to evaluate the diagnostic effects of urine PCA3 mRNA leve...
<p>(<b>A</b>) Amounts of prostate-specific membrane antigen (PSMA) (normalized by creatinine concent...
Contains fulltext : 136399.pdf (publisher's version ) (Open Access)Prostate cancer...
Purpose The discovery of new diagnostic tools for the diagnosis of prostate cancer (PCa) has become ...
<p>Detection was performed by RT-PCR <b>(A)</b>, or Western blot analyses <b>(B, C)</b>. Shown are r...
We characterized the expression and localization of pituitary adenylate cyclase-activating polypepti...
BACKGROUND:Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer ...
Objectives: Our aim was to verify whether the quantitative determination of PSA mRNA in circulating ...
Prostate-specific antigen (PSA) is important in tumour detection, monitoring disease progression and...
Objectives: The benefits of PSA (prostate specific antigen)-testing in prostate cancer remain contro...
Abstract Background Gene expression profiling has recently shown that the mRNA for CD24 is overexpre...
PCA3 is a prostate-specific non-coding RNA, with utility as urine based early detection biomarker. H...
lower ratio of free prostate-specific antigen (fPSA) to total PSA (tPSA) in serum than patients with...
Objectives. To ascertain when the serum determination of the free prostate-specific antigen (PSA)/to...
Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer (PCa). We r...
Objective: The objective of this study is to evaluate the diagnostic effects of urine PCA3 mRNA leve...
<p>(<b>A</b>) Amounts of prostate-specific membrane antigen (PSMA) (normalized by creatinine concent...
Contains fulltext : 136399.pdf (publisher's version ) (Open Access)Prostate cancer...
Purpose The discovery of new diagnostic tools for the diagnosis of prostate cancer (PCa) has become ...
<p>Detection was performed by RT-PCR <b>(A)</b>, or Western blot analyses <b>(B, C)</b>. Shown are r...
We characterized the expression and localization of pituitary adenylate cyclase-activating polypepti...
BACKGROUND:Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer ...